SRL for [the catheter]: SciMed said it `` remains committed '' both to the `` vigorous defense '' of its position that [the catheter] does n't infringe the Lilly unit 's patent , and to the pursuit of its own counterclaims , which allege Lilly engaged in antitrust violations and other wrongful acts .
<unk>